top of page

NEWS & PRESS

Plug and Play_edited.jpg

eversyn got accepted into Plug and Play

Apr 1, 2024

After being voted by Plug and Play's Food & Beverage partners, eversyn has been accepted into Plug and Play’s Accelerator - Food & Beverage - Batch 15! Over the next three months, we're set to immerse ourselves in exclusive workshops, personalized 1:1 #mentor sessions, and access to private #dealflows, all thanks to the expansive network provided by Plug and Play. This opens doors to potential pilots, proofs of concept, investments, and collaborative ventures.

1708091507767.jfif

eversyn at Global Investor Forum and Innovation for Health 2024, Rotterdam, NL

Mar 27 - 28, 2024

Global Investor Forum offers up to 30 start-up companies in the field of biotech, medtech and AI & digital health to present themselves to leading investors and other potential partners.  

Besides the pitching sessions, the programme offers also sessions and trainings aimed to improving entrepreneurials skills and insights, such as a pitch training, funding workshop and partnering session.

IMG_3442.jpg

eversyn at Future Food Tech San Francisco

Mar 21 - 22, 2024

Rachel who manages the business development of eversyn will present the future of cell-free biosynthesis in a three-minute pitch to potential partners and investors. 

9826ae47-734a-4a10-9568-7af31ac54b30.jpg

eversyn at BIO-Europe Spring 2024

Mar 18 - 20, 2024

Alberto who is spearheading the bioprocess development of eversyn will present at the eighteenth annual BIO-Europe Spring®, March 18-20, 2024, in Barcelona, Spain.

Zurich

eversyn at 17th Annual European Life Sciences CEO Forum (#Sachs_ELSF)

Feb 28 - 29, 2024

We are pleased to join the 17th Annual European Life Sciences CEO Forum (#Sachs_ELSF) that will take place on the 28th - 29th February 2024 back at the Hilton Zurich Airport Hotel. The event will be part of the Sachs Spring Life Sciences Week, which will also incorporate the 5th Annual European HealthTech CEO Forum.  

1702887888048.jfif

eversyn at BioFIT2023 in Marseille

Dec 13, 2023

We cordially invite you to join us at our exclusive pitching session, where we'll unveil how precision biotransformation can become a game changer in nutrition and biopharma production. Our founder - Dr. Thomas Rexer is eager to share our vision and engage in thought-provoking discussions with you.

IMG_4701-1536x1152_edited.jpg

eversyn at "Startup FOCUS Pitch & Connect" in Halle

Nov 13, 2023

The startup week at Martin Luther University Halle-Wittenberg (MLU ) could not have kicked off with more momentum. On the very first day, the university's transfer and start-up service transformed the Volkspark in Halle into a stage for the Startup FOCUS Pitch & Connect event. Support was provided by the International Startup Campus and Univations GmbH, which took over part of the organization and moderation of the pitches.

Meet Rachel Thu Nguyen and Sebastian Bruno Kleeberg at the NutrEvent in Rennes, France

Oct 17-18, 2023

Rachel will present the future of precision biotransformation in a five-minute pitch to potential investors. Together with Sebatian, she will be also available at the eversyn booth to answer all your questions about eversyn’s unique technology for nutrition and biopharma 🚀

1698129491286.jfif

Meet Dr. Thomas Rexer and Dr. Karim Jaen at the Festival of Biologics in Basel, Switzerland

Oct 10-12, 2023

🚀 Karim is set to unveil our Glycoengineering Toolbox, maximizing control over glycosylation for your biologics. 

Capture.PNG

Meet Rachel Thu Nguyen and Dr. Volker Landschütze at Future Food Tech in London

Sep 28-29, 2023

Rachel who manages the business development of eversyn will present the future of precision biotransformation in a three-minute pitch to potential investors. Rachel & Volker (eversyn's CEO) will be also available at the eversyn booth to answer all your questions about eversyn’s unique technology for nutrition and biopharma 🚀

Volker.jpg

eversyn appoints Dr. Ing. Volker Landschütze as new interim CEO

Jul 19, 2023

eversyn today announced the appointment of Dr. Ing. Volker Landschütze as its Chief Executive Officer, following an intensive talent search supported by Max Planck Innovation. For the first time since founded, eversyn has its first CEO.

HumanMilkConf 6-7-23_print.jpg

eversyn at the FASEB Human Milk Conference

Jun 4, 2023

This FASEB Science Research Conference (SRC) will explore the novel findings on human milk composition and bioactive function. Participants for this meeting will be principal scientists from various sectors who are interested in the breast milk area of research.

eversyn looking for interim CEO

We are looking for an interim CEO.

May 11, 2023

For preparing a spin-off, engaging in fundraising, creating a vision and strategy for growing, foundation and product positioning.

GlycoBioTec2023

eversyn to present at the GlycoBioTec2023

June 7, 2022

Our whole team will be present in person at the GlycoBioTec 2023. We are looking forward to meeting you at our booth in the exhibition hall. Moreover, we will present our technology with a talk at the conference. Stay tuned for more information.

Grant of over 0.9 Mio € to develop our technology & business

January 1, 2022

We are delighted to announce that our team is supported by an Exist research transfer grant over 0.9 Mio € from the Federal Ministry for Economics and Climate Action. eversyn will use the proprietary, cost-efficient and highly scalable technology for the synthesis of nucleotide sugars and valuable oligosaccharides.

bottom of page